The Journal of Human Immunity (JHI) inaugural editorial by JHI Editor-in-Chief Jean-Laurent Casanova is now live. and can be read online at https://doi.org/10.70962/jhi.20250001  The editorial outlines the vision, scope, and mission in making this journal the destination for exciting research into human immunity, with a particular focus on inborn errors of immunity. 

Manuscript submissions for JHI are now welcome:

• JHI publishes research articles, reviews, perspectives, letters, editorials, and commentaries that provide novel insights into the physiology and pathology of human immunity through the study of genetic defects and their phenocopies, including the study of leukocytes and other cells.
• The journal’s focus on human inborn errors of immunity encompasses conditions as diverse as infection, autoimmunity, autoinflammation, malignancy, and allergy. Human inborn errors of immunity include monogenic disorders with complete (Mendelian traits) or incomplete (non-Mendelian) penetrance.
• JHI welcomes other types of genetic basis (e.g., digenic), if causality is genetically unquestionable, or if the immunological mechanism is documented, or both.
• Single patient and single kindred genetic studies are considered, as are small and large series of patients.
• JHI will publish descriptions of new genotypes, immunological phenotypes, and clinical phenotypes, which may result from hitherto understudied ancestries or environments.

Learn more about submitting your best research in the JHI Instructions for Authors athttps://rupress.org/jhi/pages/ifora 

This news item was issued on 26 February 2025 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.